US 12,434,282 B2
Pharmaceutical waste system
David A. Maness, Mt. Pleasant, SC (US); and Brian J. VanDerWoude, Portage, MI (US)
Assigned to Stryker Corporation, Portage, MI (US)
Filed by Stryker Corporation, Kalamazoo, MI (US)
Filed on Dec. 8, 2021, as Appl. No. 17/643,344.
Application 17/643,344 is a division of application No. 16/324,273, granted, now 11,229,932, previously published as PCT/US2017/050648, filed on Sep. 8, 2017.
Claims priority of provisional application 62/430,623, filed on Dec. 6, 2016.
Claims priority of provisional application 62/385,746, filed on Sep. 9, 2016.
Prior Publication US 2022/0097109 A1, Mar. 31, 2022
Int. Cl. B09B 3/00 (2022.01); B09B 3/80 (2022.01); C02F 103/34 (2006.01)
CPC B09B 3/0075 (2013.01) [B09B 3/00 (2013.01); B09B 3/80 (2022.01); C02F 2103/343 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A method of disposing of a residual pharmaceutical composition from an IV bag with a pharmaceutical waste system including a main housing with a security mechanism, the method comprising:
coupling the IV bag to a pharmaceutical dispenser coupler;
extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler;
treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner; and
unlocking the main housing to access the pharmaceutical waste system.
 
13. A method of disposing of a residual pharmaceutical composition from an IV bag coupled to a pharmaceutical dispenser coupler, the method comprising:
extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler;
separating the extracted pharmaceutical composition into a purified waste portion and a contaminated waste portion; and
treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner.
 
19. A method of disposing of a residual pharmaceutical composition from an IV bag, the method comprising:
coupling the IV bag to a pharmaceutical dispenser coupler;
extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler;
treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner; and
analyzing at least a portion of the extracted pharmaceutical composition to determine a characteristic of the extracted pharmaceutical composition.